95 related articles for article (PubMed ID: 8385731)
1. Comparison of immunological reactivity to two major antigens of homologous and AD169 human cytomegalovirus strains during primary infection in renal transplant patients.
Rossier E; Miller H; Dal Monte P; Boccuni C; Landini MP
New Microbiol; 1993 Jan; 16(1):1-9. PubMed ID: 8385731
[TBL] [Abstract][Full Text] [Related]
2. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins.
Van Zanten J; Lazzarotto T; Campisi B; Vornhagen R; Jahn G; Landini MP; The TH
New Microbiol; 1995 Apr; 18(2):223-8. PubMed ID: 7603351
[TBL] [Abstract][Full Text] [Related]
4. Antigenic variation of cytomegalovirus isolates recovered from infected children.
Lazzarotto T; Boccuni MC; Dal Monte P; Ripalti A; Landini MP
Microbiologica; 1991 Jul; 14(3):241-51. PubMed ID: 1656167
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
Landini MP; Rossier E; Schmitz H
J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
[TBL] [Abstract][Full Text] [Related]
6. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
Essa S; Pacsa A; Said T; Nampoory MR; Raghupathy R; Johny KV; Al-Nakib W; Al-Mosawy M
Med Princ Pract; 2008; 17(1):66-70. PubMed ID: 18059104
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
Jankowski M; Styczyński P
Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis.
Lazzarotto T; Paya CV; Smith TF; Wiesner RH; Krom R; Landini MP
Microbiologica; 1992 Jan; 15(1):15-22. PubMed ID: 1313529
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus antibodies in renal transplant recipients.
Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy.
Eggers M; Radsak K; Enders G; Reschke M
J Med Virol; 2001 Feb; 63(2):135-42. PubMed ID: 11170050
[TBL] [Abstract][Full Text] [Related]
11. Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
Kim MN; Park CG; Hwang ES; Lim DG; Park JW; Seoh JY; Kook YH; Lee HJ; Choi SB; Cha CY
J Korean Med Sci; 1994 Dec; 9(6):476-81. PubMed ID: 7786444
[TBL] [Abstract][Full Text] [Related]
12. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
Eichler C; Kaden J; May G
Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
Zhang C; Shen K; Jiang Z; He X
Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
[TBL] [Abstract][Full Text] [Related]
16. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj SH; Lerner AM; Fitzgerald JT
J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
[TBL] [Abstract][Full Text] [Related]
17. Detection of neutralizing antibodies against human cytomegalovirus: influence of strain variation.
Weber B; Klinghardt U; Lux A; Braun W; Rabenau H; Doerr HW
J Med Virol; 1993 May; 40(1):28-34. PubMed ID: 8099944
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections.
O'Neill HJ; Shirodaria PV; Connolly JH; Simpson DI; McGeown MG
J Med Virol; 1988 Apr; 24(4):461-70. PubMed ID: 2835436
[TBL] [Abstract][Full Text] [Related]
20. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
